Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone on OSA Endotypes
NCT06286189Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trazodone hydrochloride prolonged-release tablets in obstructive sleep apnea (OSA), sponsored by Brigham and Women's Hospital. Started Jan 2024; status: recruiting.
02
Drugs
trazodone hydrochloride prolonged-release tablets
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06286189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06286189.